| Attribute |
Value |
| 52 Week Change |
0.26440823 |
| Address1 |
168 Third Avenue |
| All Time High |
672.34 |
| All Time Low |
0.998628 |
| Ask |
536.5 |
| Ask Size |
120 |
| Audit Risk |
2 |
| Average Analyst Rating |
1.6 - Buy |
| Average Daily Volume10 Day |
1,807,310 |
| Average Daily Volume3 Month |
2,324,818 |
| Average Volume |
2,324,818 |
| Average Volume10Days |
1,807,310 |
| Beta |
0.868 |
| Bid |
521.0 |
| Bid Size |
80 |
| Board Risk |
7 |
| Book Value |
139.75 |
| City |
Waltham |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
10 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
534.07 |
| Current Ratio |
1.526 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
537.82 |
| Day Low |
523.3456 |
| Debt To Equity |
82.903 |
| Display Name |
Thermo Fisher Scientific |
| Dividend Date |
1,792,022,400 |
| Dividend Rate |
1.88 |
| Dividend Yield |
0.36 |
| Earnings Call Timestamp End |
1,784,836,800 |
| Earnings Call Timestamp Start |
1,784,836,800 |
| Earnings Growth |
0.113 |
| Earnings Quarterly Growth |
0.096 |
| Earnings Timestamp |
1,784,809,800 |
| Earnings Timestamp End |
1,784,809,800 |
| Earnings Timestamp Start |
1,784,809,800 |
| Ebitda |
11,296,000,000 |
| Ebitda Margins |
0.24993 |
| Enterprise To Ebitda |
21.114 |
| Enterprise To Revenue |
5.277 |
| Enterprise Value |
238,504,869,888 |
| Eps Current Year |
24.85481 |
| Eps Forward |
27.25511 |
| Eps Trailing Twelve Months |
18.37 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,789,430,400 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
478.7918 |
| Fifty Day Average Change |
55.2782 |
| Fifty Day Average Change Percent |
0.11545352 |
| Fifty Two Week Change Percent |
26.440823 |
| Fifty Two Week High |
643.99 |
| Fifty Two Week High Change |
-109.91998 |
| Fifty Two Week High Change Percent |
-0.17068586 |
| Fifty Two Week Low |
403.36 |
| Fifty Two Week Low Change |
130.71002 |
| Fifty Two Week Low Change Percent |
0.32405302 |
| Fifty Two Week Range |
403.36 - 643.99 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
322,151,400,000 |
| Five Year Avg Dividend Yield |
0.26 |
| Float Shares |
370,666,398 |
| Forward Eps |
27.25511 |
| Forward P E |
19.595224 |
| Free Cashflow |
5,520,625,152 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
125,000 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.40932 |
| Gross Profits |
18,499,999,744 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0015199999 |
| Held Percent Institutions |
0.94018 |
| Implied Shares Outstanding |
371,621,465 |
| Industry |
Diagnostics & Research |
| Industry Disp |
Diagnostics & Research |
| Industry Key |
diagnostics-research |
| Ir Website |
http://ir.thermofisher.com/phoenix.zhtml?c=89145&p=irol-IRHome |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,781,481,600 |
| Last Dividend Value |
0.47 |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
834,019,200 |
| Last Split Factor |
3:2 |
| Long Business Summary |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It has strategic collaboration with genedrive plc to develop a CYP2C19 pharmacogenetic in vitro diagnostic test. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. |
| Long Name |
Thermo Fisher Scientific Inc. |
| Market |
us_market |
| Market Cap |
198,471,876,608 |
| Market State |
POSTPOST |
| Max Age |
86,400 |
| Message Board Id |
finmb_97023 |
| Most Recent Quarter |
1,774,656,000 |
| Net Income To Common |
6,848,000,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
196,405,660,467 |
| Number Of Analyst Opinions |
26 |
| Open |
525.01 |
| Operating Cashflow |
8,287,000,064 |
| Operating Margins |
0.17892 |
| Overall Risk |
9 |
| Payout Ratio |
0.0968 |
| Peg Ratio |
1.74 |
| Phone |
781 622 1000 |
| Post Market Change |
2.4299927 |
| Post Market Change Percent |
0.45499516 |
| Post Market Price |
536.5 |
| Post Market Time |
1,784,072,750 |
| Previous Close |
528.51 |
| Price Eps Current Year |
21.48759 |
| Price Hint |
2 |
| Price To Book |
3.82161 |
| Price To Sales Trailing12 Months |
4.391262 |
| Profit Margins |
0.15151 |
| Quick Ratio |
0.967 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
1.60714 |
| Region |
US |
| Regular Market Change |
5.56 |
| Regular Market Change Percent |
1.05201 |
| Regular Market Day High |
537.82 |
| Regular Market Day Low |
523.3456 |
| Regular Market Day Range |
523.3456 - 537.82 |
| Regular Market Open |
525.01 |
| Regular Market Previous Close |
528.51 |
| Regular Market Price |
534.07 |
| Regular Market Time |
1,784,059,202 |
| Regular Market Volume |
2,122,415 |
| Return On Assets |
0.04997 |
| Return On Equity |
0.13523 |
| Revenue Growth |
0.062 |
| Revenue Per Share |
120.365 |
| Sand P52 Week Change |
0.20365608 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
1 |
| Shares Outstanding |
371,621,465 |
| Shares Percent Shares Out |
0.014400001 |
| Shares Short |
5,351,535 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
4,693,391 |
| Short Name |
Thermo Fisher Scientific Inc |
| Short Percent Of Float |
0.014400001 |
| Short Ratio |
2.33 |
| Source Interval |
15 |
| State |
MA |
| Symbol |
TMO |
| Target High Price |
750.0 |
| Target Low Price |
490.0 |
| Target Mean Price |
590.7692 |
| Target Median Price |
600.0 |
| Total Cash |
3,256,000,000 |
| Total Cash Per Share |
8.762 |
| Total Debt |
43,161,001,984 |
| Total Revenue |
45,197,000,704 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
1.76 |
| Trailing Annual Dividend Yield |
0.0033301166 |
| Trailing Eps |
18.37 |
| Trailing P E |
29.072945 |
| Trailing Peg Ratio |
1.7426 |
| Triggerable |
1 |
| Two Hundred Day Average |
527.79926 |
| Two Hundred Day Average Change |
6.270752 |
| Two Hundred Day Average Change Percent |
0.011880942 |
| Type Disp |
Equity |
| Volume |
2,122,415 |
| Website |
https://www.thermofisher.com |
| Zip |
2,451 |